Immunohistochemical analysis of bcl-2, bax, bcl-X, and mcl-1 expression in prostate cancers.
Impact in
- Oncology 148
Classified as
- Journal
- PubMed
In The Last Decade
doi.org/w74341859 →Countries where authors are citing Immunohistochemical analysis of bcl-2, bax, bcl-X, and mcl-1 expression in prostate cancers.
This map shows the geographic impact of Immunohistochemical analysis of bcl-2, bax, bcl-X, and mcl-1 expression in prostate cancers.. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Immunohistochemical analysis of bcl-2, bax, bcl-X, and mcl-1 expression in prostate cancers. with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Immunohistochemical analysis of bcl-2, bax, bcl-X, and mcl-1 expression in prostate cancers. more than expected).
Fields of papers citing Immunohistochemical analysis of bcl-2, bax, bcl-X, and mcl-1 expression in prostate cancers.
This network shows the impact of Immunohistochemical analysis of bcl-2, bax, bcl-X, and mcl-1 expression in prostate cancers.. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the Immunohistochemical analysis of bcl-2, bax, bcl-X, and mcl-1 expression in prostate cancers..
About Immunohistochemical analysis of bcl-2, bax, bcl-X, and mcl-1 expression in prostate cancers.
This paper, published in 1996, received 524 indexed citations . Written by S Krajewski, JI Epstein, Ahmed Shabaik, Jurgita Sauvageot, Ki Byung Song, Shinichi Kitada and John C. Reed covering the research area of Molecular Biology, Epidemiology and Oncology. It is primarily cited by scholars working on Molecular Biology (293 citations), Oncology (148 citations), Pulmonary and Respiratory Medicine (100 citations), Cancer Research (86 citations) and Immunology (48 citations). Published in PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
This paper is also available at doi.org/w74341859.